annual working capital:
$2.63B+$846.38M(+47.57%)Summary
- As of today (July 1, 2025), BMRN annual working capital is $2.63 billion, with the most recent change of +$846.38 million (+47.57%) on December 31, 2024.
- During the last 3 years, BMRN annual working capital has risen by +$897.55 million (+51.94%).
- BMRN annual working capital is now at all-time high.
Performance
BMRN Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$2.84B+$214.25M(+8.16%)Summary
- As of today (July 1, 2025), BMRN quarterly working capital is $2.84 billion, with the most recent change of +$214.25 million (+8.16%) on March 31, 2025.
- Over the past year, BMRN quarterly working capital has increased by +$942.58 million (+49.68%).
- BMRN quarterly working capital is now at all-time high.
Performance
BMRN quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
BMRN Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +47.6% | +49.7% |
| 3 y3 years | +51.9% | +49.2% |
| 5 y5 years | +160.0% | +119.2% |
BMRN Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +51.9% | at high | +59.6% |
| 5 y | 5-year | at high | +160.0% | at high | +64.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
BMRN Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.84B(+8.2%) |
| Dec 2024 | $2.63B(+47.6%) | $2.63B(+12.2%) |
| Sep 2024 | - | $2.34B(+6.8%) |
| Jun 2024 | - | $2.19B(+15.6%) |
| Mar 2024 | - | $1.90B(+6.6%) |
| Dec 2023 | $1.78B(-17.7%) | $1.78B(-0.7%) |
| Sep 2023 | - | $1.79B(-23.8%) |
| Jun 2023 | - | $2.35B(+4.9%) |
| Mar 2023 | - | $2.24B(+3.8%) |
| Dec 2022 | $2.16B(+25.2%) | $2.16B(+0.0%) |
| Sep 2022 | - | $2.16B(+5.3%) |
| Jun 2022 | - | $2.05B(+7.8%) |
| Mar 2022 | - | $1.90B(+10.2%) |
| Dec 2021 | $1.73B(-6.6%) | $1.73B(-3.8%) |
| Sep 2021 | - | $1.80B(-6.2%) |
| Jun 2021 | - | $1.91B(+3.0%) |
| Mar 2021 | - | $1.86B(+0.5%) |
| Dec 2020 | $1.85B(+83.2%) | $1.85B(-1.8%) |
| Sep 2020 | - | $1.88B(+2.7%) |
| Jun 2020 | - | $1.83B(+41.6%) |
| Mar 2020 | - | $1.30B(+28.3%) |
| Dec 2019 | $1.01B(-34.1%) | $1.01B(-26.1%) |
| Sep 2019 | - | $1.37B(-0.1%) |
| Jun 2019 | - | $1.37B(-3.4%) |
| Mar 2019 | - | $1.42B(-7.6%) |
| Dec 2018 | $1.53B(+10.2%) | $1.53B(-2.3%) |
| Sep 2018 | - | $1.57B(+6.4%) |
| Jun 2018 | - | $1.48B(+0.5%) |
| Mar 2018 | - | $1.47B(+5.5%) |
| Dec 2017 | $1.39B(+41.5%) | $1.39B(-14.8%) |
| Sep 2017 | - | $1.63B(+50.5%) |
| Jun 2017 | - | $1.08B(+7.1%) |
| Mar 2017 | - | $1.01B(+3.1%) |
| Dec 2016 | $982.48M(+52.5%) | $982.48M(-23.8%) |
| Sep 2016 | - | $1.29B(+73.9%) |
| Jun 2016 | - | $741.37M(+22.6%) |
| Mar 2016 | - | $604.78M(-6.1%) |
| Dec 2015 | $644.18M(-44.6%) | $644.18M(-17.9%) |
| Sep 2015 | - | $785.10M(-9.4%) |
| Jun 2015 | - | $866.23M(-28.8%) |
| Mar 2015 | - | $1.22B(+4.8%) |
| Dec 2014 | $1.16B(+21.8%) | $1.16B(+33.4%) |
| Sep 2014 | - | $871.27M(-17.3%) |
| Jun 2014 | - | $1.05B(-3.4%) |
| Mar 2014 | - | $1.09B(+14.3%) |
| Dec 2013 | $954.15M(+66.5%) | $954.15M(+74.8%) |
| Sep 2013 | - | $545.85M(-5.7%) |
| Jun 2013 | - | $578.68M(-0.1%) |
| Mar 2013 | - | $579.02M(+1.1%) |
| Dec 2012 | $573.00M(+52.5%) | $573.00M(-2.0%) |
| Sep 2012 | - | $584.46M(+4.1%) |
| Jun 2012 | - | $561.54M(+42.7%) |
| Mar 2012 | - | $393.58M(+4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $375.68M(-10.6%) | $375.68M(-7.0%) |
| Sep 2011 | - | $403.77M(-6.6%) |
| Jun 2011 | - | $432.08M(+1.0%) |
| Mar 2011 | - | $427.84M(+1.8%) |
| Dec 2010 | $420.42M(+7.9%) | $420.42M(-9.0%) |
| Sep 2010 | - | $462.09M(+5.5%) |
| Jun 2010 | - | $437.98M(+3.9%) |
| Mar 2010 | - | $421.73M(+8.3%) |
| Dec 2009 | $389.57M(-35.9%) | $389.57M(-14.6%) |
| Sep 2009 | - | $456.20M(+2.1%) |
| Jun 2009 | - | $446.95M(-23.9%) |
| Mar 2009 | - | $587.26M(-3.3%) |
| Dec 2008 | $607.62M(+4.3%) | $607.62M(+5.4%) |
| Sep 2008 | - | $576.28M(-9.7%) |
| Jun 2008 | - | $638.39M(+1.3%) |
| Mar 2008 | - | $630.42M(+8.2%) |
| Dec 2007 | $582.75M(+102.2%) | $582.75M(-1.6%) |
| Sep 2007 | - | $592.17M(-0.7%) |
| Jun 2007 | - | $596.39M(+111.6%) |
| Mar 2007 | - | $281.82M(-2.2%) |
| Dec 2006 | $288.18M(+908.5%) | $288.18M(-2.7%) |
| Sep 2006 | - | $296.14M(-3.5%) |
| Jun 2006 | - | $306.80M(-4.7%) |
| Mar 2006 | - | $321.87M(+1026.5%) |
| Dec 2005 | $28.57M(+89.2%) | $28.57M(-24.7%) |
| Sep 2005 | - | $37.96M(-969.5%) |
| Jun 2005 | - | -$4.37M(-250.3%) |
| Mar 2005 | - | $2.90M(-80.8%) |
| Dec 2004 | $15.11M(-92.9%) | $15.11M(-76.8%) |
| Sep 2004 | - | $64.97M(-35.2%) |
| Jun 2004 | - | $100.32M(-48.2%) |
| Mar 2004 | - | $193.66M(-8.8%) |
| Dec 2003 | $212.45M(+186.2%) | $212.45M(-10.7%) |
| Sep 2003 | - | $237.96M(-8.4%) |
| Jun 2003 | - | $259.80M(+82.9%) |
| Mar 2003 | - | $142.08M(+91.4%) |
| Dec 2002 | $74.22M(-42.2%) | $74.22M(-10.6%) |
| Sep 2002 | - | $83.02M(-15.1%) |
| Jun 2002 | - | $97.82M(-14.2%) |
| Mar 2002 | - | $113.99M(-11.3%) |
| Dec 2001 | $128.48M(+241.2%) | $128.48M(+188.4%) |
| Sep 2001 | - | $44.55M(-23.8%) |
| Jun 2001 | - | $58.46M(+81.4%) |
| Mar 2001 | - | $32.22M(-14.4%) |
| Dec 2000 | $37.66M(-38.6%) | $37.66M(-21.2%) |
| Sep 2000 | - | $47.80M(-5.7%) |
| Jun 2000 | - | $50.71M(-10.8%) |
| Mar 2000 | - | $56.87M(-7.3%) |
| Dec 1999 | $61.34M(+467.9%) | $61.34M(-13.4%) |
| Sep 1999 | - | $70.80M(+436.4%) |
| Jun 1999 | - | $13.20M(+238.5%) |
| Mar 1999 | - | $3.90M |
| Dec 1998 | $10.80M | - |
FAQ
- What is BioMarin Pharmaceutical annual working capital?
- What is the all time high annual working capital for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual working capital year-on-year change?
- What is BioMarin Pharmaceutical quarterly working capital?
- What is the all time high quarterly working capital for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly working capital year-on-year change?
What is BioMarin Pharmaceutical annual working capital?
The current annual working capital of BMRN is $2.63B
What is the all time high annual working capital for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual working capital is $2.63B
What is BioMarin Pharmaceutical annual working capital year-on-year change?
Over the past year, BMRN annual working capital has changed by +$846.38M (+47.57%)
What is BioMarin Pharmaceutical quarterly working capital?
The current quarterly working capital of BMRN is $2.84B
What is the all time high quarterly working capital for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly working capital is $2.84B
What is BioMarin Pharmaceutical quarterly working capital year-on-year change?
Over the past year, BMRN quarterly working capital has changed by +$942.58M (+49.68%)